Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib. The gene discussed is BRAF; the disease is thyroid gland papillary carcinoma.